中国著名防疫专家钟南山,早前力挺能改善冠状病毒状况的连花清瘟胶囊,虽然已在新加坡注册为中成药,却不代表当局认可该胶囊可作为治疗或缓解冠毒的药物。

卫生科学局称,根据该胶囊成分的功效,批准为能缓解伤风感冒状况的中成药,或辅助健康产品来进行销售。

当局表示,基于仍未有科学证据能够证实,有关胶囊能治疗或缓解冠毒,因此并没有将其批准为相关治疗方面的药物。

早前中国著名防疫专家钟南山曾经指出,连花清瘟胶囊在治疗冠毒上能起到一些作用,改善病患的症状。负责连花清瘟胶囊的出产商以岭药业,日前也宣布该胶囊已经获得我国卫生科学局核准,批下了中成药的注册。

卫生科学局指出,只是将此款胶囊以辅助健康产品核准,因此商家和卖家都不可以向消费者做出“错误”宣传。当局表示,绝对不会对做出误导性宣传的卖家或商家手软,一旦被提控且罪名成立,将可能面对不超过一年的监禁、或罚款不超过2两元、或两者兼施。

无论如何,当局促请消费者向知名零售商购买这款辅助健康产品,且身患有严重疾病者也应该直接就医,不要擅自用药。

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Train services on the East-West Line disrupted on Friday morning due to a track fault.

Train services on the East-West Line were disrupted on Friday morning due…

Roy Ngerng apologises to PM, asks for open dialogue on CPF issues

Blogger, Roy Ngerng Yi Ling has issued a letter of apology to…

Author Sudhir Vadaketh challenges Mediacorp claim of merit-based hiring

Channel NewsAsia (CNA) is Singapore’s equivalent of Russia Today where its journalists…

Unemployed Singaporean PMET: No success with government’s WSG and e2i

A 43-year-old unemployed Singaporean PMET wrote to transitioning.org recently, lamenting about initiatives…